Food Empire · Squad Capital

Investment conclusionACCUMULATE SELECTIVELYConviction: High

Food Empire remains the leading published SGX compounder after 1H2026: revenue grew 15.0% and normalized NPAT rose 12.2%, Central Asia accelerated before a full Kazakhstan contribution, and South Asia remains capacity constrained. The result is good rather than exceptional because operating profit grew slower than revenue, Southeast Asia softened in 2Q and peak capex plus working capital absorbed cash. At S$2.42, the base case relies on double-digit earnings growth and a mid-teens exit multiple rather than further rerating.

Price used: S$2.42
Base-case IRR: 11%–14%
Horizon: 3–5 years
Portfolio role: Growth compounder / selective accumulation

Principal risk: Russia and currency concentration.

2. Quick metrics

Price (14 Aug 2026)S$2.42

Income yieldS$0.04 interim declared; full-year yield depends on final payout

Base-case IRR11%–14%

Normalized forward P/EMid-teens

Base exit multiple15–17x

Operating cash flowUS$26.1m

3. What the company does

Business overview

Food Empire is a Singapore-headquartered branded food and beverage group. Its core products are instant coffee mixes and soluble coffee sold under brands including MacCoffee and CaféPHỐ, supplemented by tea, chocolate beverages and snacks. It sells in more than 60 countries and operates a vertically integrated network of manufacturing facilities and distribution offices.

How it makes money

Builds local consumer brands, distributes through established channels and captures manufacturing economics rather than acting only as a brand licensor.
Russia and Central Asia are the largest profit pools; Southeast Asia and South Asia provide diversification and the next capacity-led growth leg.
Retained cash is being reinvested in coffee-mix, spray-dried and freeze-dried capacity, so the investment case depends on utilisation and returns on new plants.

4. Core investment thesis

Central Asia is becoming a second core growth engine

1H2026 Central Asia revenue increased more than 30% and segment profit grew faster, before a full contribution from the new Kazakhstan coffee-mix plant. The next test is whether 2H utilisation converts capacity into sustained segment profit rather than one-off channel fill.

Capacity supports growth, but returns now matter more than announcements

India is running near full capacity, Kazakhstan is operational and further India and Vietnam projects extend the runway. With several projects overlapping, the investment case should be judged on utilisation, margin, working capital and free cash flow rather than installed capacity alone.

Operating leverage remains unproven after 1H2026

Revenue grew 15% but operating profit grew about 10%, as marketing and brand-building costs rose. Cheaper coffee and scale can still lift margins, but 2H2026 and FY2027 must show that the benefit reaches operating profit rather than being fully reinvested.

Diversification is real but uneven

Central Asia is scaling rapidly and South Asia is capacity constrained, yet Southeast Asia slowed sharply in 2Q and Russia remains a major profit pool with meaningful FX translation. The valuation should therefore retain a concentration discount until non-Russia profits compound more consistently.

5. Main earnings drivers

Each row links an economic variable to the earnings mechanism, the assumption embedded in the base case and the company-specific KPIs that can validate or disprove it.

Driver	How it changes earnings	Current direction	Base-case assumption	Key measurable indicators
Kazakhstan and Central Asia utilisation	Higher coffee-mix capacity supports volume, distribution and fixed-cost absorption. Segment profit growth demonstrates whether the new plant is earning an acceptable return.	Strongly positive; 2H contribution still to prove	Central Asia remains a double-digit growth region and Kazakhstan adds incremental revenue and segment profit from 2H2026.	Central Asia revenue growth Central Asia segment profit and margin Kazakhstan utilisation commentary Inventory and receivables growth in the region
Russia underlying demand and FX	Local-currency volumes and pricing determine the underlying franchise while ruble moves affect reported US-dollar revenue and profit. Forecasts should strip out translation tailwinds before extrapolating growth.	Positive underlying; FX-assisted reported growth	Local-currency demand remains healthy, but reported growth normalises as the FX tailwind fades.	Russia reported revenue growth Ruble movement versus US dollar Management price-versus-volume commentary Russia segment profit margin
Vietnam and Southeast Asia growth	Vietnam remains the main Southeast Asia brand engine. Revenue growth must resume after a soft 2Q without promotional intensity overwhelming segment margins.	Watch after 2Q slowdown	Southeast Asia returns to mid-to-high-single-digit growth over the next several quarters while segment profit remains healthy.	Southeast Asia quarterly revenue Vietnam commentary Selling and marketing expense Southeast Asia segment profit
India capacity and 2027 expansion	Near-full spray-dried and freeze-dried utilisation caps current volume. New spray-dried capacity should release the constraint and support branded plus OEM growth if completed on schedule.	Positive, capacity constrained	Existing plants stay well utilised and the 60% spray-dried expansion is completed by end-2027 without material cost overruns.	South Asia revenue Plant utilisation commentary India capex progress Commissioning date and incremental volume
Margin conversion	Coffee, creamer, packaging and freight costs interact with pricing, marketing and fixed-cost absorption. Commodity relief creates value only if gross-profit gains exceed reinvestment in selling and brand-building.	Flat to mildly negative in 1H2026	Operating margin recovers above 15% and trends gradually higher as coffee costs and utilisation improve.	Gross margin Operating margin EBITDA margin Selling and marketing expense as a percentage of sales Coffee-cost commentary
Cash conversion and capital allocation	Receivables and capex determine whether accounting earnings become distributable cash. Simultaneous factory projects create value only if incremental ROIC exceeds the cost of capital.	Weak in 1H2026; balance sheet still sound	Working-capital absorption moderates and operating cash flow begins to cover the expansion programme as Kazakhstan and Malaysia ramp.	Operating cash flow Receivables growth versus sales Capital expenditure Net cash after borrowings and REN Ordinary DPS and buybacks

6. Evidence for and against the thesis

This table tests each thesis claim with both supporting and disconfirming evidence. Confidence refers to the evidence currently available, not the attractiveness of the share price.

Thesis claim	Evidence supporting it	Contradictory evidence or unresolved issue	Confidence
Central Asia is becoming a second core growth engine	1H2026 Central Asia revenue rose 33.6% Segment profit increased materially faster than group operating profit Kazakhstan coffee-mix capacity is operational with positive contribution expected from 2H2026	The full utilisation curve and project-level return are not yet disclosed Early growth can include channel build and launch spending	Medium–High
Capacity supports a multi-year growth runway	India facilities are operating near full capacity The India spray-dried expansion is intended to add about 60% capacity by end-2027 Vietnam freeze-dried capacity extends the runway into 2028	Peak capex has already pushed 1H free cash flow negative on a simple CFO-less-capex basis Several projects are overlapping and require proof of utilisation and cash returns	Medium–High
Operating leverage should emerge as input costs ease and plants fill	Group revenue still grew 15% and normalized NPAT 12.2% Lower coffee prices and higher future utilisation provide plausible margin tailwinds	1H operating profit grew only 10.2% Operating margin slipped to about 15.0% from 15.6% Selling and marketing expense grew faster than revenue	Medium
Diversification is reducing but not eliminating concentration risk	Central Asia is scaling rapidly South Asia demand is constrained by capacity rather than weak utilisation Asia had already surpassed traditional markets in 1Q2026 revenue	Southeast Asia slowed to 2.4% growth in 1H and implied 2Q declined modestly Russia remains a major profit pool and reported growth was materially FX-assisted	High

7. Financial and margin profile

Metric	Current	Interpretation
1H2026 revenue	US$315.1m	+15.0% year on year
1H2026 EBITDA	US$58.8m	+12.7%; growth slower than revenue
1H2026 operating profit	US$47.1m	+10.2%; operating margin about 15.0% versus 15.6%
Normalized NPAT	US$35.3m	+12.2%; excludes REN fair-value distortion in the prior period
Central Asia revenue	US$60.5m	+33.6%; segment profit about US$16.0m
Southeast Asia revenue	US$79.3m	+2.4%; implied 2Q revenue modestly lower year on year
Operating cash flow	US$26.1m	Down from US$32.4m as receivables absorbed cash
Capital expenditure	US$30.1m	Up from US$11.9m; peak expansion phase
Cash / bank borrowings	US$151.3m / US$63.5m	REN liabilities add a further US$37.2m obligation

Margins and operating leverage

Gross profit rose broadly in line with revenue, but operating profit increased only 10.2% versus 15.0% revenue growth. Selling and marketing expenditure increased materially as management continued brand-building and promotions.
The result therefore does not yet validate the earlier operating-leverage assumption. Lower coffee prices can still help, but the benefit may be reinvested in marketing before it reaches operating margin.
Cash conversion is temporarily weaker because receivables and capex are rising during the expansion phase. This is acceptable only if Kazakhstan, India and later Vietnam deliver visible incremental profit and free cash flow.

8. Balance sheet & capital allocation

Operating cash flow: US$26.1m
Cash / bank borrowings: US$151.3m / US$63.5m

Capital-allocation priorities and catalysts

Visible Kazakhstan revenue and profit contribution in 2H2026
Operating-margin recovery as coffee costs and utilisation improve
India spray-dried expansion progressing toward end-2027 completion
Vietnam reacceleration and later freeze-dried capacity
Sustained dividend growth or buybacks without compromising expansion returns

9. Valuation summary

Metric	Current / normalized	Interpretation
Normalized forward P/E	Mid-teens	At S$2.42 using normalized FY2026 earnings rather than reported REN-distorted EPS
Base exit multiple	15–17x	No further premium rerating assumed
Base-case earnings growth	≈10%–12%	Requires Kazakhstan contribution, India capacity release and no structural Vietnam slowdown
Interim dividend	S$0.04	Higher than the prior interim payout on a bonus-adjusted basis
Preferred framework	Normalized P/E + FCF conversion + ROIC on new plants	Cash returns on new capacity are now the key valuation test

10. Return scenarios (3–5 years)

Scenario	Assumptions	Indicative annual return
Bear	Vietnam remains soft, Russia reported growth normalises with FX, new plants ramp slowly, operating margin stays around 14%–15% and the exit P/E falls to 12–13x.	2%–7% annualised
Base	Normalized EPS compounds about 10%–12%, Kazakhstan contributes from 2H2026, India capacity is released on schedule, margins recover gradually and the exit P/E is 15–17x.	11%–14% annualised
Bull	Kazakhstan and India ramp quickly, Vietnam reaccelerates, coffee-cost relief produces margin expansion and diversification supports a 17–19x exit P/E.	17%–20%+ annualised

Squad Capital estimates, not company guidance. Refresh when price, normalized earnings or risk changes materially.

11. Key risks

Russia and currency concentration
Vietnam growth remains weak after heavy marketing
Selling and marketing absorbs commodity-cost relief
Working capital and capex keep free cash flow weak
Poor returns on simultaneous factory investments
REN conversion and related dilution or accounting volatility

Thesis breakers

Operating profit continues to lag revenue despite lower coffee prices
Southeast Asia remains flat or negative for several quarters
Working capital and capex absorb most operating cash flow into FY2027
New capacity requires persistent discounting or fails to earn acceptable returns

12. Thesis monitoring dashboard

Only indicators capable of materially changing the forecast, risk assessment or investment conclusion are included here.

Thesis-critical indicator	Current reading	Base-case requirement	Status
Kazakhstan and Central Asia contribution	Central Asia revenue +33.6% in 1H2026; new Kazakhstan plant operational	Visible 2H revenue and segment-profit contribution with sustained double-digit growth	On track
Operating margin	About 15.0% in 1H2026 versus 15.6% in 1H2025	Recover above 15% and trend higher as commodity and utilisation tailwinds emerge	Watch
Southeast Asia growth	+2.4% in 1H2026; implied 2Q modestly negative year on year	Return to mid-to-high-single-digit growth without material margin sacrifice	Watch
Cash conversion through capex	US$26.1m operating cash flow versus US$30.1m capex in 1H2026	Working capital normalises and operating cash flow increasingly funds the expansion programme	Watch
India capacity release	Current facilities near full capacity; expansion targeted by end-2027	Project remains on schedule and preserves high utilisation before commissioning	On track
Russia underlying versus FX growth	Reported 1H revenue +24.6% with a material ruble tailwind	Healthy local-currency volume and pricing even if reported growth slows	On track

13. Primary sources

▣Food Empire investor relationsOpen ↗▣1H2026 condensed interim financial statementsOpen ↗▣1Q2026 press releaseOpen ↗▣FY2025 results announcementOpen ↗▣Company analyst-report libraryOpen ↗

14. Revision history

Date	Price	View	What changed
16 Aug 2026	S$2.42 (14 Aug close)	Accumulate selectively	1H2026 confirms double-digit normalized earnings growth and strengthens the Central Asia capacity case, but operating leverage is not yet visible and cash conversion weakened during peak capex. Base-case IRR is reset to 11%–14%; the next proof points are Kazakhstan contribution, Vietnam reacceleration and margin recovery.
2 Aug 2026	S$2.35 (28 Jul close)	Accumulate	Price-only refresh for the UltraGreen comparison. The business thesis is unchanged; the higher price trims the base-case IRR to 12%–16%.
19 Jul 2026	S$2.28	Accumulate	Initial current SGX publication using normalized FY2025 earnings, 1Q2026 revenue momentum and capacity-return monitoring.

Food Empire (F03)